Corticotropin for Behçet's disease mouth ulcers
Part of Eyes & vision, Genetic & congenital, Heart & circulation, Mouth & dental, Skin clinical trials.
This study tests a medication called corticotropin (a hormone that may help control inflammation) to see if it can reduce symptoms of Behçet's disease, especially painful mouth ulcers. If you have active ulcers, this treatment might help you get relief.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have a confirmed diagnosis of Behçet's disease for at least 3 months.
- You need to have at least 2 active mouth ulcers at the time of screening.
- You must be able to give written consent and attend all study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if ustekinumab or apremilast can help control Behçet's disease symptoms like mouth and genital ulcers, skin sores, and joint pain. It may be an option if standard treatments haven't worked well.
This study tests a new pill called Hemay005 for adults with Behçet's disease who have at least two mouth sores that need treatment beyond creams or rinses. It aims to see if the drug safely reduces mouth ulcers.
This trial studies lenalidomide to treat frequent, ongoing mouth ulcers caused by mucosal Behçet’s syndrome. It’s meant for people whose mouth sores keep coming back despite standard treatments like steroid medicines and other immune-suppressing drugs.
This Phase 2 trial tests tocilizumab and tofacitinib to see if they can better control vascular (blood-vessel) Behçet’s syndrome. It may help by lowering inflammation and reducing complications from aneurysms in the aorta or peripheral arteries.
This trial tests baricitinib, an oral medication, for people with intestinal Behçet's disease that hasn't improved with standard treatments. It aims to see if baricitinib can reduce symptoms and help heal gut ulcers.
This trial tests a new medicine, HSK44459, to see if it can reduce mouth ulcers in people with Behçet's disease. If you have frequent mouth sores from Behçet's, this treatment might help.
Hear when a new Behçet's Syndrome (BS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.